Financhill
Back

TG Therapeutics Stock Predictions

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 21% based on the past 28 years of stock performance.
  • TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $35.17. The Score for TGTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • TGTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 21% based on the past 28 years of stock performance.

TG Therapeutics Stock Rating

Sell
49
TG Therapeutics (TGTX) is a Sell

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
46.48
52-Week Low:
16.39

Prediction Charts

Market Cap:
5.6B
Price in USD:
35.17
Volume:
1.7M
Beta:
0.92

Technical Analysis

SMA50:
37.18
SMA100:
36.21
SMA200:
31.89
52-Wk Change:
109.69%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 35.17 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 35.56 35.08 35.60 34.41
Jun-2 35.05 35.75 35.99 34.32
Jun-3 35.50 36.41 37.05 35.30
Jun-4 37.00 37.04 37.23 36.18
Jun-5 37.01 39.30 40.09 36.33
Jun-6 39.81 40.06 40.54 39.41
Jun-9 40.61 39.84 40.99 39.39
Jun-10 39.81 39.43 40.40 39.14
Jun-11 39.45 38.32 39.75 38.11
Jun-12 37.68 37.37 38.88 37.11
Jun-13 36.55 36.01 37.19 35.88
Jun-16 36.48 35.63 36.75 35.43
Jun-17 35.06 35.00 35.52 34.55
Jun-18 35.52 35.17 35.71 34.03

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.18 per share, an increase this year of $0.77 per share, and an increase next year of $0.85 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.